Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $2.214B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 600,000 | $119M | 5.4% | $180.30 | — | SPONSORED ADR | 04351P101 |
| ACLX | Arcellx Inc | 1,250,000 | $103M | 4.6% | $64.66 | +11.3% | COMMON STOCK | 03940C100 |
| NUVL | Nuvalent Inc | 1,100,000 | $95.13M | 4.3% | $86.50 | -8.6% | COM | 670703107 |
| ABVX | Abivax SA | 1,000,000 | $84.9M | 3.8% | $84.90 | — | SPONSORED ADS | 00370M103 |
| ALC | Alcon AG | 1,100,000 | $81.96M | 3.7% | $86.36 | -3.4% | ORD SHS | H01301128 |
| BCAX | Bicara Therapeutics Inc | 5,100,000 | $80.53M | 3.6% | $14.08 | -20.5% | COM | 055477103 |
| FOLD | Amicus Therapeutics Inc | 9,750,000 | $76.83M | 3.5% | $7.78 | -8.5% | COM | 03152W109 |
| GMED | Globus Medical Inc | 1,250,000 | $71.59M | 3.2% | $62.68 | -8.1% | CL A | 379577208 |
| IONS | Ionis Pharmaceuticals Inc | 1,075,000 | $70.33M | 3.2% | $41.34 | +18.1% | COM | 462222100 |
| JAZZ | Jazz Pharmaceuticals PLC | 500,000 | $65.9M | 3.0% | $108.63 | +10.4% | SHS USD | G50871105 |
| BDX | Becton Dickinson & Co | 325,000 | $60.83M | 2.7% | $183.78 | +0.2% | COM | 075887109 |
| SRRK | Scholar Rock Holding Corp | 1,500,000 | $55.86M | 2.5% | $37.53 | -6.8% | COM | 80706P103 |
| IMTX | Immatics NV | 6,350,000 | $54.1M | 2.4% | $9.24 | -33.4% | SHS | N44445109 |
| RGEN | Repligen Corp | 400,000 | $53.47M | 2.4% | $121.47 | 0.0% | COM | 759916109 |
| DNTH | Dianthus Therapeutics Inc | 1,180,000 | $46.43M | 2.1% | $21.02 | +21.6% | COM | 252828108 |
| BMRN | BioMarin Pharmaceutical Inc | 830,000 | $44.95M | 2.0% | $58.21 | -1.8% | COM | 09061G101 |
| XENE | Xenon Pharmaceuticals Inc | 1,100,000 | $44.16M | 2.0% | $37.23 | -5.4% | COM | 98420N105 |
| DXCM | Dexcom Inc | 650,000 | $43.74M | 2.0% | $79.14 | 0.0% | COM | 252131107 |
| CYTK | Cytokinetics Inc | 725,000 | $39.85M | 1.8% | $61.56 | -33.1% | COM NEW | 23282W605 |
| BIIB | Biogen Inc | 275,000 | $38.52M | 1.7% | $135.17 | 0.0% | COM | 09062X103 |
| — | Cidara Therapeutics Inc | 400,000 | $38.3M | 1.7% | $21.54 | — | COM NEW | 171757206 |
| — | Astria Therapeutics Inc | 4,956,000 | $36.08M | 1.6% | $10.07 | — | COM | 04635X102 |
| DYN | Dyne Therapeutics Inc | 2,775,000 | $35.1M | 1.6% | $12.17 | -6.2% | COM | 26818M108 |
| TYRA | Tyra Biosciences Inc | 2,425,000 | $33.93M | 1.5% | $14.73 | -22.6% | COM | 90240B106 |
| ABT | Abbott Laboratories | 250,000 | $33.48M | 1.5% | $130.60 | +0.0% | COM | 002824100 |
| IRON | Disc Medicine Inc | 500,000 | $33.04M | 1.5% | $55.98 | +6.3% | COM | 254604101 |
| NRIX | Nurix Therapeutics Inc | 3,475,000 | $32.11M | 1.4% | $12.51 | -17.0% | COM | 67080M103 |
| CRNX | Crinetics Pharmaceuticals Inc | 750,000 | $31.24M | 1.4% | $37.35 | -14.4% | COM | 22663K107 |
| CLDX | Celldex Therapeutics Inc | 1,205,000 | $31.17M | 1.4% | $20.34 | +13.9% | COM NEW | 15117B202 |
| ZYME | Zymeworks Inc | 1,765,000 | $30.15M | 1.4% | $12.80 | +11.8% | COM | 98985Y108 |
| DHR | Danaher Corp | 150,000 | $29.74M | 1.3% | $204.57 | -3.0% | COM | 235851102 |
| RVMD | Revolution Medicines Inc | 630,000 | $29.42M | 1.3% | $38.42 | +1.9% | COM | 76155X100 |
| RAPP | Rapport Therapeutics Inc | 950,000 | $28.21M | 1.3% | $17.84 | 0.0% | COM | 75383L102 |
| ELVN | Enliven Therapeutics Inc | 1,160,000 | $23.75M | 1.1% | $19.89 | +1.3% | COM | 29337E102 |
| GERN | Geron Corp | 17,225,000 | $23.6M | 1.1% | $3.11 | -57.1% | COM | 374163103 |
| BLTE | Belite Bio Inc | 312,500 | $23.13M | 1.0% | $74.00 | — | SPONSORED ADS | 07782B104 |
| RARE | Ultragenyx Pharmaceutical Inc | 750,000 | $22.56M | 1.0% | $29.99 | 0.0% | COM | 90400D108 |
| VERA | Vera Therapeutics Inc | 760,000 | $22.09M | 1.0% | $34.48 | -32.9% | CL A | 92337R101 |
| LXEO | Lexeo Therapeutics Inc | 3,250,000 | $21.58M | 1.0% | $6.61 | -26.8% | COM | 52886X107 |
| BDTX | Black Diamond Therapeutics Inc | 5,550,000 | $21.03M | 0.9% | $5.15 | -43.2% | COM | 09203E105 |
| DAWN | Day One Biopharmaceuticals Inc | 2,675,000 | $18.86M | 0.9% | $12.02 | -42.7% | COM | 23954D109 |
| SLDB | Solid Biosciences Inc | 2,975,000 | $18.36M | 0.8% | $7.41 | -21.0% | COM NEW | 83422E204 |
| AXSM | Axsome Therapeutics Inc | 150,000 | $18.22M | 0.8% | $112.64 | 0.0% | COM | 05464T104 |
| TSHA | Taysha Gene Therapies Inc | 5,500,000 | $17.98M | 0.8% | $2.47 | +14.5% | COM SHS | 877619106 |
| APGE | Apogee Therapeutics Inc | 425,000 | $16.89M | 0.8% | $38.18 | 0.0% | COM | 03770N101 |
| SVRA | Savara Inc | 4,015,000 | $14.33M | 0.6% | $4.17 | -29.2% | COM | 805111101 |
| BRKR | Bruker Corp | 440,000 | $14.3M | 0.6% | $46.46 | -23.5% | COM | 116794108 |
| REGN | Regeneron Pharmaceuticals Inc | 25,000 | $14.06M | 0.6% | $564.28 | 0.0% | COM | 75886F107 |
| QURE | uniQure NV | 225,000 | $13.13M | 0.6% | $9.25 | +96.3% | SHS | N90064101 |
| BBNX | Beta Bionics Inc | 600,000 | $11.92M | 0.5% | $14.44 | +21.7% | COM | 08659B102 |
| BHVN | Biohaven Ltd | 701,700 | $10.53M | 0.5% | — | — | Put | G1110E107 |
| INSP | Inspire Medical Systems Inc | 135,000 | $10.02M | 0.5% | $101.25 | 0.0% | COM | 457730109 |
| KALV | KalVista Pharmaceuticals Inc | 750,000 | $9.135M | 0.4% | $12.01 | +15.1% | COM | 483497103 |
| LNTH | Lantheus Holdings Inc | 170,000 | $8.719M | 0.4% | $69.94 | -10.6% | COM | 516544103 |
| — | Applied Therapeutics Inc | 14,250,000 | $8.62M | 0.4% | $1.06 | — | COM | 03828A101 |
| CGON | CG Oncology Inc | 175,000 | $7.049M | 0.3% | $29.07 | 0.0% | COM | 156944100 |
| VYGR | Voyager Therapeutics Inc | 1,475,000 | $6.888M | 0.3% | $6.46 | — | COM | 92915B106 |
| TVRD | Tvardi Therapeutics Inc | 167,000 | $6.508M | 0.3% | $28.47 | 0.0% | COM | 140755307 |
| VTYX | Ventyx Biosciences Inc | 2,050,000 | $6.375M | 0.3% | $3.49 | -24.2% | COM | 92332V107 |
| GLUE | Monte Rosa Therapeutics Inc | 800,000 | $5.928M | 0.3% | $5.30 | 0.0% | COM | 61225M102 |
| GSK | GSK PLC | 125,000 | $5.395M | 0.2% | $43.16 | — | SPONSORED ADR | 37733W204 |
| NVCR | Novocure Ltd | 400,000 | $5.168M | 0.2% | $13.36 | 0.0% | ORD SHS | G6674U108 |
| AGIO | Agios Pharmaceuticals Inc | 127,000 | $5.098M | 0.2% | $37.61 | 0.0% | COM | 00847X104 |
| NYXH | Nyxoah SA | 1,107,413 | $5.094M | 0.2% | $8.73 | -25.0% | SHS | B6S7WD106 |
| MYGN | Myriad Genetics Inc | 600,000 | $4.338M | 0.2% | $5.94 | 0.0% | COM | 62855J104 |
| EXAS | Exact Sciences Corp | 75,000 | $4.103M | 0.2% | $50.80 | -1.7% | COM | 30063P105 |
| ESTA | Establishment Labs Holdings In | 100,000 | $4.099M | 0.2% | $40.85 | 0.0% | COM | G31249108 |
| KOD | Kodiak Sciences Inc | 250,000 | $4.093M | 0.2% | $8.62 | 0.0% | COM | 50015M109 |
| ANRO | Alto Neuroscience Inc | 950,000 | $3.819M | 0.2% | $11.40 | -70.9% | COM SHS | 02157Q109 |
| ARQT | Arcutis Biotherapeutics Inc | 200,000 | $3.77M | 0.2% | $14.94 | +5.6% | COM | 03969K108 |
| RCUS | Arcus Biosciences Inc | 250,000 | $3.4M | 0.2% | $10.40 | 0.0% | COM | 03969F109 |
| FATE | Fate Therapeutics Inc | 2,515,000 | $3.169M | 0.1% | $3.20 | -66.3% | COM | 31189P102 |
| ALEC | Alector Inc | 980,000 | $2.901M | 0.1% | $1.45 | +52.4% | COM | 014442107 |
| ENGN | Engene Holdings Inc | 370,000 | $2.527M | 0.1% | $7.77 | -41.3% | COM | 29286M105 |
| PASG | Passage Bio Inc | 305,000 | $2.449M | 0.1% | $6.96 | 0.0% | COM NEW | 702712209 |
| — | Sutro Biopharma Inc | 2,600,000 | $2.258M | 0.1% | $1.83 | — | COM | 869367102 |
| OKUR | OnKure Therapeutics Inc | 635,000 | $1.746M | 0.1% | $15.14 | -83.6% | COM CL A | 68277Q105 |
| LUNG | Pulmonx Corp | 830,000 | $1.345M | 0.1% | $2.09 | 0.0% | COM | 745848101 |
| MGNX | MacroGenics Inc | 280,000 | $470K | 0.0% | $14.22 | -88.6% | COM | 556099109 |
| TENX | Tenax Therapeutics Inc | 53,439 | $407K | 0.0% | $3.62 | +68.6% | COM NEW | 88032L605 |
| TRAW | Traws Pharma Inc | 150,000 | $278K | 0.0% | $5.36 | -69.6% | COM NEW | 68232V884 |